Abstract

BackgroundPersistent Pseudomonas aeruginosa (PPA) infection promotes lung function deterioration in children with cystic fibrosis (CF). Although early CF diagnosis through newborn screening (NBS) has been shown to provide nutritional/growth benefit, it is unclear whether NBS lowers the risk of PPA infection and how the effect of NBS vary with age. Modeling the onset age of PPA infection is challenging because 1) the onset age of PPA infection is interval censored in patient registry data; and 2) some risk factors such as NBS may have time-varying effects.MethodsThis problem fits into the framework of a recently developed Bayesian dynamic Cox model for interval censored data, where each regression coefficient is allowed to be time-varying to an extent determined by the data.ResultsApplication of the methodology to data from the CF Foundation Patient Registry revealed interesting findings. Compared with patients with meconium ileus or diagnosed through signs or symptoms, patients diagnosed through NBS had significantly lower risks of acquiring PPA infection between age 1 and 2 years, and the benefit in survival rate was found to last up to age 4 years. Two cohorts of five years apart were compared. Patients born in cohort 2003–2004 had significantly lower risks of the PPA infections at any age up to 4 years than those born in 1998–1999.ConclusionsThe study supports benefits of NBS on PPA infection in early childhood. In addition, our analyses demonstrate that patients in the more recent cohort had significantly lower risks of acquiring PPA infection up to age 4 years, which suggests improved CF treatment and care over time.Electronic supplementary materialThe online version of this article (doi:10.1186/s12874-016-0220-5) contains supplementary material, which is available to authorized users.

Highlights

  • Persistent Pseudomonas aeruginosa (PPA) infection promotes lung function deterioration in children with cystic fibrosis (CF)

  • To make a fair comparison between the two cohorts, we excluded data after age 5 years from patients in BC[98–99] because patients in BC[03–04] had no data after age 5 years reported in the 2008 CFF Patient Registry (CFFPR)

  • The age window we report for the persistent PA (PPA) infection, was chosen to be (0, 4) years, because at the data extraction time, patients born in 2004 did not reach 5 years old yet, and the definition of PPA involves at least two visits of 4–9 months apart

Read more

Summary

Introduction

Persistent Pseudomonas aeruginosa (PPA) infection promotes lung function deterioration in children with cystic fibrosis (CF). Early CF diagnosis through newborn screening (NBS) has been shown to provide nutritional/growth benefit, it is unclear whether NBS lowers the risk of PPA infection and how the effect of NBS vary with age. Cystic fibrosis (CF) is a potentially lethal, lifelong recessive genetic disorder found mostly among Caucasians, affecting over 30,000 people in the United States [1]. It is caused by mutations in the gene for the cystic fibrosis transmembrane conductance regular protein. It is very important to characterize PPA infection in CF patients for treatment devise and patient management

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call